Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07621783
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context
Sponsor: Imelda GI Clinical Research Center
View on ClinicalTrials.gov
Summary
Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.
Official title: Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context: LEADER Trial.
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-05-01
Completion Date
2026-12-31
Last Updated
2026-06-02
Healthy Volunteers
No
Interventions
DIAGNOSTIC_TEST
Leucine-rich α2-glycoprotein
Leucine-rich α2-glycoprotein measurement
Locations (1)
Imelda General Hospital
Bonheiden, Belgium